220 related articles for article (PubMed ID: 21216283)
1. Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.
Boppart MD; Burkin DJ; Kaufman SJ
Biochim Biophys Acta; 2011 Apr; 1812(4):439-46. PubMed ID: 21216283
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
3. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
4. Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury.
Boppart MD; Burkin DJ; Kaufman SJ
Am J Physiol Cell Physiol; 2006 Jun; 290(6):C1660-5. PubMed ID: 16421207
[TBL] [Abstract][Full Text] [Related]
5. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
6. Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F.
Milner DJ; Kaufman SJ
Am J Pathol; 2007 Feb; 170(2):609-19. PubMed ID: 17255329
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy.
Gurpur PB; Liu J; Burkin DJ; Kaufman SJ
Am J Pathol; 2009 Mar; 174(3):999-1008. PubMed ID: 19179609
[TBL] [Abstract][Full Text] [Related]
8. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
9. PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle.
Feron M; Guevel L; Rouger K; Dubreil L; Arnaud MC; Ledevin M; Megeney LA; Cherel Y; Sakanyan V
Am J Pathol; 2009 Apr; 174(4):1459-70. PubMed ID: 19264909
[TBL] [Abstract][Full Text] [Related]
10. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
11. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo.
Shavlakadze T; Chai J; Maley K; Cozens G; Grounds G; Winn N; Rosenthal N; Grounds MD
J Cell Sci; 2010 Mar; 123(Pt 6):960-71. PubMed ID: 20179101
[TBL] [Abstract][Full Text] [Related]
12. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice.
Burkin DJ; Wallace GQ; Milner DJ; Chaney EJ; Mulligan JA; Kaufman SJ
Am J Pathol; 2005 Jan; 166(1):253-63. PubMed ID: 15632017
[TBL] [Abstract][Full Text] [Related]
14. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts.
Yazid MD; Hung-Chih C
Cell Commun Signal; 2021 Oct; 19(1):105. PubMed ID: 34706731
[TBL] [Abstract][Full Text] [Related]
16. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
17. PTRH2 gene mutation causes progressive congenital skeletal muscle pathology.
Doe J; Kaindl AM; Jijiwa M; de la Vega M; Hu H; Griffiths GS; Fontelonga TM; Barraza P; Cruz V; Van Ry P; Ramos JW; Burkin DJ; Matter ML
Hum Mol Genet; 2017 Apr; 26(8):1458-1464. PubMed ID: 28175314
[TBL] [Abstract][Full Text] [Related]
18. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
20. Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice.
Lang JM; Esser KA; Dupont-Versteegden EE
Exp Biol Med (Maywood); 2004 Jun; 229(6):503-11. PubMed ID: 15169969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
